ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 389 filers reported holding ASTRAZENECA PLC in Q3 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $360,000 | +16.9% | 7,197 | +27.9% | 0.18% | +55.3% |
| Q3 2020 | $308,000 | -1.0% | 5,628 | -28.4% | 0.11% | +936.4% |
| Q3 2018 | $311,000 | -37.7% | 7,859 | -57.0% | 0.01% | -45.0% |
| Q4 2016 | $499,000 | -34.4% | 18,271 | -27.5% | 0.02% | -33.3% |
| Q2 2016 | $761,000 | -9.5% | 25,218 | -15.6% | 0.03% | -9.1% |
| Q1 2016 | $841,000 | -54.1% | 29,875 | -44.7% | 0.03% | -54.2% |
| Q4 2015 | $1,833,000 | -12.5% | 53,989 | +64.1% | 0.07% | -4.0% |
| Q2 2015 | $2,096,000 | +471.1% | 32,902 | +513.7% | 0.08% | +476.9% |
| Q1 2015 | $367,000 | -61.4% | 5,361 | -60.3% | 0.01% | -59.4% |
| Q4 2014 | $951,000 | +338.2% | 13,512 | +345.8% | 0.03% | +357.1% |
| Q3 2014 | $217,000 | -82.0% | 3,031 | -83.7% | 0.01% | -78.8% |
| Q1 2014 | $1,205,000 | -7.4% | 18,573 | -15.2% | 0.03% | -13.2% |
| Q4 2013 | $1,301,000 | -72.3% | 21,906 | -78.0% | 0.04% | -75.8% |
| Q2 2013 | $4,701,000 | – | 99,390 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |